ESCAPE-NA1 Trial Brings Hope of Neuroprotective Drugs for Acute Ischemic Stroke – Highlights of the Phase 3 Clinical Trial on Nerinetide

 

Xin-Fu Zhou1

1 Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia

 

Abstract

Keywords

[SpringerLink]